Cargando…
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
The use of rapid molecular tests may anticipate the identification of causative agents and resistance determinants in the blood of critically ill patients with sepsis. From April to December 2021, all intensive care unit patients with sepsis or septic shock who were tested with the T2Bacteria and T2...
Autores principales: | Giacobbe, Daniele Roberto, Crea, Francesca, Morici, Paola, Magnasco, Laura, Di Pilato, Vincenzo, Briano, Federica, Willison, Edward, Pincino, Rachele, Dettori, Silvia, Tutino, Stefania, Esposito, Simone, Coppo, Erika, Dentone, Chiara, Portunato, Federica, Mikulska, Malgorzata, Robba, Chiara, Vena, Antonio, Battaglini, Denise, Brunetti, Iole, Ball, Lorenzo, Pelosi, Paolo, Marchese, Anna, Bassetti, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774778/ https://www.ncbi.nlm.nih.gov/pubmed/36551480 http://dx.doi.org/10.3390/antibiotics11121823 |
Ejemplares similares
-
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021) -
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
por: Briano, Federica, et al.
Publicado: (2022) -
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
por: Taramasso, Lucia, et al.
Publicado: (2021) -
Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?
por: Magnasco, Laura, et al.
Publicado: (2021) -
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
por: Vena, Antonio, et al.
Publicado: (2020)